跳至主要内容
临床试验/NCT05586919
NCT05586919已完成不适用

Treatment of Venous Malformation by Direct Puncture Repair: Ethanol Versus Polidocanol

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Disfigurement questionnaire

研究概览

简要总结

Vascular malformations are birth defects that happen when different stages of angiogenesis shut down. 44 - 64% of all vascular malformations are venous malformations (VMs). Sclerotherapy is the first treatment line for VMs. It acts by getting rid of the vascular endothelial cells in the lesion. One of the most common and well researched sclerosing agents for VMs is polidocanol, which is a popular counterpart for concentrated ethanol.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Months 至 36 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with venous malformation of both genders and age above one year.

排除标准

  • Age below one year.
  • Patients had any other vascular malformations.
  • Indication for contrast material or Alcohol and polidocanol injection.
  • Unfit for general anesthesia. 5) Pregnancy. 6) Skin infection, inflammation, and ulcers.
  • Pulmonary embolism.
  • Acute Ischemia, and acute DVT.

结局指标

主要结局

Disfigurement questionnaire

时间窗: 6 months post operative

Disfigurementof the affected part may be unchanged, or decreased or disppeared, or relapsed

Heaviness questionnaire

时间窗: 6 months post operative

Heaviness of the affected part may be unchanged, or decreased or disppeared, or relapsed

size of venous malformation

时间窗: 6 months post operative

it assess the size of malformations after injection; which may be unchanged, or decreased or disppeared, or relapsed

Degree of satisfaction

时间窗: 6 months post operative

It may be; Very satisfied, or satisfied, or not satisfied, or Dissatisfied.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Walied Khereba

Principal Investigator

Al-Azhar University

研究点 (1)

Loading locations...

相似试验

招募中
2 期
Treatment of congenital vascular malformations using Sirolimus: improving quality of Life
NL-OMON45838Radboud Universitair Medisch Centrum75
进行中(未招募)
1 期
Treatment of congenital vascular malformations with Sirolimuscongenital vascular malformation : Vascular malformationscan involve lymphatic vessels, capillaries, veins and arteries or even combinations. These vascularmalformations are present at birth and grow with the child.MedDRA version: 20.0Level: HLTClassification code 10047091Term: Vascular malformations and acquired anomaliesSystem Organ Class: 100000005125MedDRA version: 20.0Level: LLTClassification code 10047090Term: Vascular malformation peripheralSystem Organ Class: 100000158692MedDRA version: 20.0Level: PTClassification code 10070181Term: Gastrointestinal vascular malformationSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.0Level: PTClassification code 10074979Term: Vascular malformationSystem Organ Class: 10010331 - Congenital, familial and genetic disorders
EUCTR2016-002157-38-NLRadboud University Medical Center75
Unknown
3 期
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of LifeVascular Malformations
NCT03987152Radboud University Medical Center75
招募中
不适用
Treatment of Low-flow Venous Malformations With Electrosclerotherapy. Prospective Observational StudyVascular Malformations
NCT06189092Istituto Ortopedico Rizzoli65
尚未招募
不适用
Venous Malformation and Coagulatiodeep vein thrombosisvenous malformation10014523venous thromboembolism
NL-OMON32975Academisch Medisch Centrum100